The article cites the authors’ analysis of hospital data, which shows unexpectedly high rates of antibiotic resistance in several bacteria, including:
- A. baumanii to carbapenems, greater than 50 percent (CDC: 11 percent), rendering carbapenems obsolete for treatment.
- E. coli to third generation cephalosporins, between 8 and 11 percent (CDC: 5 percent)
- K. pneumonia to third generation cephalosporins, between 20 and 27 percent (CDC: 15 percent)
The article also determines that the Food and Drug Administration’s pledge to renew efforts in antibiotic development has fallen short of its goals.
The authors call for “a complete overhaul” of approaches to antibiotic resistance, disease and prevention, according to a digest of the article by ScienceDaily.
More Articles on Quality:
7 Biggest Safety Challenges in the OR
U.S. News Responds to Criticism of Best Hospital List
Sharps Safety Law Effectively Decreased Injury 33%, Study Says
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
